Hepatoprotective Effect Of Epigallocatechin-Gallate (Egcg) And Sorafenib Against Den Induced Hepato Cellular Carcinoma In Experimental Animals. Journal of Pharmaceutical Negative Results. Published online November 14, 2022:921-929. Accessed June 6, 2026. https://www.pnrjournal.com/index.php/home/article/view/3403